Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousStem CellsBone MarrowHematologic NeoplasmsTransplantation ChimeraBone Marrow CellsPeripheral Blood Stem Cell TransplantationTissue DonorsBusulfanHematopoietic Stem CellsWhole-Body IrradiationGraft SurvivalTreatment OutcomeLeukemiaRecurrenceRemission InductionHistocompatibility TestingGraft vs Leukemia EffectLiver TransplantationGraft vs Tumor EffectMyeloablative AgonistsAnemia, AplasticLeukemia, Myeloid, AcuteImmunosuppressive AgentsCombined Modality TherapyHistocompatibilityLeukemia, Myelogenous, Chronic, BCR-ABL PositiveVidarabineLymphocyte TransfusionCyclophosphamideRetrospective StudiesLymphocyte DepletionMultiple MyelomaPrecursor Cell Lymphoblastic Leukemia-LymphomaCord Blood Stem Cell TransplantationMyelodysplastic SyndromesSurvival AnalysisCytomegalovirus InfectionsHepatic Veno-Occlusive DiseaseKidney TransplantationTime FactorsDisease-Free SurvivalSurvival RateMesenchymal Stem Cell TransplantationEmbryonic Stem CellsBone and BonesSalvage TherapyMinor Histocompatibility AntigensAntilymphocyte SerumSiblingsMelphalanTransplantation, IsogeneicT-LymphocytesAcute DiseaseNeoplasm, ResidualAdult Stem CellsAntineoplastic Combined Chemotherapy ProtocolsCell DifferentiationHematopoietic Stem Cell MobilizationTransplantation ImmunologyChimerismHLA AntigensImmunosuppressionLeukemia, MyeloidBone Marrow PurgingHematologic DiseasesGraft RejectionHematopoiesisCell TransplantationFollow-Up StudiesAntigens, CD34Mice, Inbred C57BLVirus ActivationLymphoma, Non-HodgkinCytarabineHeart TransplantationLeukocyte TransfusionPrognosisCytomegalovirusNuclear FamilyCyclosporinePluripotent Stem CellsPrimary MyelofibrosisGranulocyte Colony-Stimulating FactorFlow CytometryCells, CulturedHodgkin DiseaseStem Cell NicheLung TransplantationMesenchymal Stromal CellsBone Marrow DiseasesImmunocompromised HostRadiation ChimeraActuarial Analysis